Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2025-12-25 @ 8:03 PM
Study NCT ID:
NCT05808335
Status:
UNKNOWN
Last Update Posted:
2023-06-15
First Post:
2023-03-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)
Sponsor:
ImmuneMed, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-27
First Submit QC Date:
None
Study First Post Date:
2023-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-12
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL